ECSP982362A - Compuestos de quinolina y quinazolina utiles en terapia - Google Patents

Compuestos de quinolina y quinazolina utiles en terapia

Info

Publication number
ECSP982362A
ECSP982362A ECSP982362A ECSP982362A EC SP982362 A ECSP982362 A EC SP982362A EC SP982362 A ECSP982362 A EC SP982362A EC SP982362 A ECSP982362 A EC SP982362A
Authority
EC
Ecuador
Prior art keywords
therapy
compounds useful
quinoline
quinazoline compounds
quinazoline
Prior art date
Application number
Other languages
English (en)
Inventor
Fox David Nathan Abraham
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP982362 priority Critical patent/ECSP982362A/es
Publication of ECSP982362A publication Critical patent/ECSP982362A/es

Links

Abstract

Esta invención se refiere a nuevos compuestos útiles en terapia, particularmente en el tratamiento de la hiperplasia prostática benigna.
ECSP982362 1998-01-08 1998-01-08 Compuestos de quinolina y quinazolina utiles en terapia ECSP982362A (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP982362 ECSP982362A (es) 1998-01-08 1998-01-08 Compuestos de quinolina y quinazolina utiles en terapia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP982362 ECSP982362A (es) 1998-01-08 1998-01-08 Compuestos de quinolina y quinazolina utiles en terapia

Publications (1)

Publication Number Publication Date
ECSP982362A true ECSP982362A (es) 1998-12-22

Family

ID=42043285

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP982362 ECSP982362A (es) 1998-01-08 1998-01-08 Compuestos de quinolina y quinazolina utiles en terapia

Country Status (1)

Country Link
EC (1) ECSP982362A (es)

Similar Documents

Publication Publication Date Title
NO993396D0 (no) Kinolin- ig kinolinforbindelser nyttige i terapi, spesielt i behandlingen av benign prostatisk hyperplasi
DE60023982D1 (de) System zur Behandlung von benigner Prostatahyperplasie
NO20014560L (no) Quinasoliner og terapautisk anvendelse derav
DE60033658D1 (de) Behandlung von prostata-krebs mit anti-erbb2 antikörpern
TR200103216T2 (tr) Pirimidinon bileşimleri
TR199801195T2 (xx) Tedavide yararl� kinolin ve kinozilin bile�ikleri.
AU3011299A (en) Combination therapy for the treatment of benign prostatic hyperplasia
DE60009888T2 (de) Substituierte 3-cyano-[1.7], [1.5] und [1.8]naphthyridininhibitoren von tyrosin kinasen
ATE361075T1 (de) Pharmazeutische kombination zur behandlung von benigner prostatahyperplasie oder zur langzeitvorbeugung von akuter harnzurückhaltung
PT984777E (pt) Piperazinas arilsubstituidas uteis no tratamento da hiperplasia benigna da prostata
ZA991315B (en) Novel substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia.
ECSP982362A (es) Compuestos de quinolina y quinazolina utiles en terapia
NO20005548L (no) Mykobakterieinhibitorer
EA200401100A1 (ru) 1α-ФТОР-25-ГИДРОКСИ-16,23E-ДИЕН-26,27-БИСГОМО-20-ЭПИХОЛЕКАЛЬЦИФЕРОЛ И ЕГО ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ
ZA991319B (en) Novel phthalimido arylpiperazines useful in the treatment of benign prostatic hyperplasia.
TR200003084T2 (tr) Paroxetine askorbat
GT199700003A (es) Compuestos de quinolina y quinazolina utiles en terapia.
DE69807166D1 (de) Prostata-spezifische Antigen Inhibitore
GB9810895D0 (en) Combination therapy for the treatment of benign prostatic hyperplasia